Quest Diagnostics Inc (DGX, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Quest Diagnostics Inc provides diagnostic testing, information, and services, providing insights that enable patients and physicians to make healthcare decisions. It provides diagnostics for insurers and healthcare information technology businesses. Quest Diagnostics Inc has a market cap of $11.85 billion; its shares were traded at around $87.79 with a P/E ratio of 16.60 and P/S ratio of 1.64. The dividend yield of Quest Diagnostics Inc stocks is 2.30%. Quest Diagnostics Inc had annual average EBITDA growth of 3.00% over the past ten years.
For the last quarter Quest Diagnostics Inc reported a revenue of $1.8 billion, compared with the revenue of $2.2 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $7.5 billion, a decrease of 2.3% from the previous year. For the last five years Quest Diagnostics Inc had an average revenue growth rate of 1.1% a year.
The reported diluted earnings per share was $5.29 for the year, a decline of 3.8% from the previous year. Over the last five years Quest Diagnostics Inc had an EPS growth rate of 2.3% a year. The Quest Diagnostics Inc had a decent operating margin of 14.67%, compared with the operating margin of 15.11% a year before. The 10-year historical median operating margin of Quest Diagnostics Inc is 14.89%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, Quest Diagnostics Inc has the cash and cash equivalents of $135.0 million, compared with $137.0 million in the previous year. The long term debt was $3.4 billion, compared with $3.7 billion in the previous year. The interest coverage to the debt is at a comfortable level of 25.8. Quest Diagnostics Inc has a financial strength rank of 6 (out of 10).
At the current stock price of $87.79, Quest Diagnostics Inc is traded at 19.6% premium to its historical median P/S valuation band of $73.40. The P/S ratio of the stock is 1.64, while the historical median P/S ratio is 1.35. The stock lost 11.04% during the past 12 months.
For the complete 20-year historical financial data of DGX, click here.
